Wound healing: Captopril, an angiogenesis inhibitor, and Staphylococcus aureus peptidoglycan

Journal of Surgical Research

Volumn 92, Issue 2, 2000, Pages 177-185

  Qiu, Jian Gian ^a   Factor, Stephen ^a   Chang, Tsueng H ^a   Knighton, David ^b   Nadel, Howard ^c   Levenson, Stanley M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Institute for Reparative Medicine and Vascular Surgery   (United States)

^c JACOBI MEDICAL CENTER   (United States)

Author keywords

Captopril; Peptidoglycan; Staphylococcus aureus; Wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PEPTIDOGLYCAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN INCISION; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

EID: 0033866529     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5839     Document Type: Article

References (41)

1. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats
2. Captopril: Pharmacology, metabolism, and disposition
3. Angiotensin-converting enzyme inhibitors in hypertension
4. Angiotensin converting enzyme inhibitors: Present and future
5. Inhibition of angiogenesis in Kaposi's sarcoma by captopril
6. Accelerating effects of non-viable Staphylococcus aureus, its cell wall, and cell wall peptidoglycan
7. Non-viable Staph. aureus and its peptidoglycan stimulate macrophage recruitment, angiogenesis, fibroplasia and collagen accumulation in wound healing
8. Molecular mechanisms under-lying wound healing acceleration by Staphylococcus aureus peptidoglycan
9. Single local instillation of nonviable Staphylococcus aureus or its peptidoglycan ameliorates glucocorticoid-induced impaired wound healing
10. Staphylococcus aureus peptidoglycan ameliorates cyclophosphamide- induced impairment of wound healing
11. A fractionation procedure for studies of the synthesis of cell-wall mucopeptide and of other polymers in cells of Staphylococcus aureus
12. Some studies on wound healing: Experimental methods, effect of ascorbic acid and effect of deuterium oxide
13. The healing of rat skin wounds
14. Determination of hydroxyproline in connective tissues
15. Neovascularization produced by angiotensin II
16. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo
17. Acceleration of dermal tissue repair by angiotensin II
18. Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats
19. Captopril inhibits the 72 kDa matrix metalloproteinases
20. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon- sensitive metalloprotease with acidic pH optimum
21. Tissue inhibitor of metalloproteinases inhibits bFGF-induced human microvascular endothelial cell proliferation
22. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors
23. Effects of converting-enzyme inhibitors on the renin-angiotensin- aldosterone, bradykinin and arachidonic acid-prostaglandin systems: Correlation of chemical structure and biologic activity
24. Role of sulfhydryl groups in the stimulatory effect of captopril on vascular prostacyclin synthesis
25. Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins
26. Wound fluids from saline solution- and Staphylococcus aureus peptidoglycan-inoculated sponges induce expression of matrix metalloproteinase 13 messenger ribonucleic acid by cultured rat flbroblasts
27. Changes in skin angiotensin II receptors in rats during wound healing
28. Alterations of angiotensin II receptor levels in sutured wounds in rat skin
29. Fibrous tissue and angiotensin II
30. Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma
31. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model
32. Use of 'granuloma pouch' technique in the study of antiphlogistic corticoids
33. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction
34. Modulation of fibroblastic cytochemical features during wound healing and fibrosis
35. The stow of myofibroblasts
36. Growth factor control of wound healing angiogenesis
37. Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors
38. Reversal of the wound healing deficit in diabetic rats by combined basic flbroblast growth factor and transforming growth factor-1 therapy
39. What is the evidence that tumors are angiogenesis dependent?
40. Angiogenesis in cancer, vascular, rheumatoid and other diseases
41. Angiogenesis and angiogenesis inhibition: An overview